BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32920325)

  • 1. Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review.
    Pauling JD; Hackett N; Guida A; Merkel PA
    Semin Arthritis Rheum; 2020 Oct; 50(5):1114-1130. PubMed ID: 32920325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary Clinical and Laser Speckle Contrast Analysis Data on Selexipag Efficacy for the Treatment of Digital Vasculopathy in Systemic Sclerosis.
    Di Battista M; Della Rossa A; Da Rio M; De Mattia G; Morganti R; Mosca M
    J Rheumatol; 2023 Aug; 50(8):1029-1031. PubMed ID: 37003608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon.
    Wilkinson JD; Leggett SA; Marjanovic EJ; Moore TL; Allen J; Anderson ME; Britton J; Buch MH; Del Galdo F; Denton CP; Dinsdale G; Griffiths B; Hall F; Howell K; MacDonald A; McHugh NJ; Manning JB; Pauling JD; Roberts C; Shipley JA; Herrick AL; Murray AK
    Arthritis Rheumatol; 2018 Jun; 70(6):903-911. PubMed ID: 29457381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Laser Speckle Contrast Imaging to Assess Digital Microvascular Function in Primary Raynaud Phenomenon and Systemic Sclerosis: A Comparison Using the Raynaud Condition Score Diary.
    Pauling JD; Shipley JA; Hart DJ; McGrogan A; McHugh NJ
    J Rheumatol; 2015 Jul; 42(7):1163-8. PubMed ID: 26034146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis.
    Correa MJ; Andrade LE; Kayser C
    Arthritis Res Ther; 2010; 12(4):R157. PubMed ID: 20696074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raynaud's phenomenon and digital ulcers: advances in evaluation and management.
    Herrick AL
    Curr Opin Rheumatol; 2021 Nov; 33(6):453-462. PubMed ID: 34420003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.
    Ingegnoli F; Schioppo T; Allanore Y; Caporali R; Colaci M; Distler O; Furst DE; Hunzelmann N; Iannone F; Khanna D; Matucci-Cerinic M
    Semin Arthritis Rheum; 2019 Feb; 48(4):686-693. PubMed ID: 29706243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.
    Gaillard-Bigot F; Roustit M; Blaise S; Gabin M; Cracowski C; Seinturier C; Imbert B; Carpentier P; Cracowski JL
    Microvasc Res; 2014 Jul; 94():90-5. PubMed ID: 24990822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for laser speckle contrast analysis (LASCA) in predicting the outcome of digital ulcers in patients with systemic sclerosis?
    Barsotti S; d'Ascanio A; Valentina V; Chiara S; Silvia B; Laura A; Mosca M; Della Rossa A
    Clin Rheumatol; 2020 Jan; 39(1):69-75. PubMed ID: 31317425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term data on efficacy and safety of selexipag for scleroderma digital vasculopathy.
    Di Battista M; Della Rossa A; Mosca M
    J Rheumatol; 2024 Jun; ():. PubMed ID: 38879188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon.
    Teaw S; Gupta A; Williams A; Wilson FP; Sumpio BJ; Sumpio BE; Hinchcliff M
    Arthritis Res Ther; 2023 Jan; 25(1):10. PubMed ID: 36670487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary.
    Motegi SI; Sekiguchi A; Saito S; Ishibuchi H; Kishi C; Yasuda M; Ishikawa O
    J Dermatol; 2018 Mar; 45(3):349-352. PubMed ID: 29164658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review.
    Maltez N; Hughes M; Brown E; Hickey V; Shea B; Herrick AL; Proudman S; Merkel PA; Pauling JD
    Semin Arthritis Rheum; 2023 Aug; 61():152208. PubMed ID: 37202251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeatability of high-resolution laser Doppler images of the hands in patients with systemic sclerosis and secondary Raynaud's phenomenon.
    Britton J
    Photodermatol Photoimmunol Photomed; 2023 May; 39(3):193-203. PubMed ID: 32181935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].
    Correa MJ; Mariz HA; Andrade LE; Kayser C
    Rev Bras Reumatol; 2014; 54(6):452-8. PubMed ID: 25458027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study assessing pathophysiology and healing of digital ulcers in patients with systemic sclerosis using laser Doppler imaging and thermography.
    Murray AK; Moore TL; Wragg E; Ennis H; Vail A; Dinsdale G; Muir L; Griffiths CE; Herrick AL
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):100-105. PubMed ID: 27749241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and persistence of intravenous iloprost in systemic sclerosis.
    Martins P; Dourado E; Fonseca JE; Romão V; Resende C
    ARP Rheumatol; 2022; 1(2):122-128. PubMed ID: 35810370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raynaud's phenomenon (primary or secondary to systemic sclerosis). The usefulness of laser-Doppler flowmetry in the diagnosis.
    Del Bianco E; Magini B; Muscarella G; Cappugi P; Lotti T
    Int Angiol; 2001 Dec; 20(4):307-13. PubMed ID: 11782697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.